We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSPS icon
1601
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$245M
$134K 0.01%
3,915
-28,430
-88% -$952K
ZD icon
1602
Ziff Davis
ZD
$1.97B
$134K 0.01%
1,696
-7,390
-81% -$595K
GBCI icon
1603
Glacier Bancorp
GBCI
$6.39B
$133K 0.01%
2,674
-7,342
-73% -$396K
UAA icon
1604
Under Armour
UAA
$2.29B
$133K 0.01%
13,052
-9,433
-42% -$81.6K
CIEN icon
1605
Ciena
CIEN
$54.9B
$132K 0.01%
2,583
-2,648
-51% -$120K
DON icon
1606
WisdomTree US MidCap Dividend Fund
DON
$4.09B
$132K 0.01%
3,190
+1,986
+165% +$82.1K
HAE icon
1607
Haemonetics
HAE
$3.97B
$132K 0.01%
1,679
-3,095
-65% -$249K
NWG icon
1608
NatWest
NWG
$75.8B
$132K 0.01%
20,387
+17,893
+717% +$105K
API
1609
Agora
API
$395M
$131K 0.01%
33,528
+33,251
+12,004% +$110K
ARQT icon
1610
Arcutis Biotherapeutics
ARQT
$3.3B
$131K 0.01%
8,865
+6,035
+213% +$105K
CRAI icon
1611
CRA International
CRAI
$1.06B
$131K 0.01%
1,069
+100
+10% +$11K
GSHD icon
1612
Goosehead Insurance
GSHD
$2.32B
$131K 0.01%
3,789
-4,437
-54% -$166K
KOF icon
1613
Coca-Cola Femsa
KOF
$23B
$131K 0.01%
1,933
+113
+6% +$7.36K
LNN icon
1614
Lindsay Corp
LNN
$1.17B
$131K 0.01%
804
+339
+73% +$55.9K
NMRK icon
1615
Newmark Group
NMRK
$2.62B
$131K 0.01%
16,444
+3,462
+27% +$28.9K
PB icon
1616
Prosperity Bancshares
PB
$8.85B
$131K 0.01%
1,797
-3,623
-67% -$261K
AMG icon
1617
Affiliated Managers Group
AMG
$9.48B
$130K 0.01%
821
-2,635
-76% -$373K
ESNT icon
1618
Essent Group
ESNT
$6.08B
$130K 0.01%
3,335
-42,683
-93% -$1.62M
FFIN icon
1619
First Financial Bankshares
FFIN
$4.99B
$130K 0.01%
3,774
-14,484
-79% -$548K
FINX icon
1620
Global X FinTech ETF
FINX
$166M
$130K 0.01%
6,736
+6,735
+673,500% +$136K
LNC icon
1621
Lincoln National
LNC
$8.51B
$130K 0.01%
4,223
-15,625
-79% -$620K
NOG icon
1622
Northern Oil and Gas
NOG
$2.58B
$130K 0.01%
4,223
-3,008
-42% -$101K
VO icon
1623
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$130K 0.01%
2,560
+2,360
+1,180% +$120K
VRN
1624
DELISTED
Veren
VRN
$130K 0.01%
18,280
-29,538
-62% -$219K
AVEO
1625
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$130K 0.01%
8,703
+5,964
+218% +$82.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.